Moderna Inc (NASDAQ:MRNA)
| 160.14 Delayed Data As of Apr 14 |  +10.32 / +6.89%Today’s Change | 33.15 Today|||52-Week Range 189.26 | +53.29% Year-to-Date |
Latest MRNA News | Press Releases
Today’s Trading
| Previous close | 149.71 |
| Today’s open | 153.66 |
| Day’s range | 152.49 - 160.92 |
| Volume | 15,389,838 |
| Average volume (3 months) | 15,962,414 |
| Market cap | $56.4B |
Data as of 5:28pm ET, 04/14/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,257.59% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | NM |
| Price/Sales | 49.59 |
| Price/Book | 21.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | -5.08 | -1.26% |
| BIIBBiogen | -0.40 | -0.15% |
| GILDGilead Sciences | +0.41 | +0.63% |
| EXASExact Sciences Corp | -0.86 | -0.67% |
Data as of 5:13pm ET, 04/14/2021
Financials
| Next reporting date | May 13, 2021 |
| EPS forecast (this quarter) | $3.11 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
